Hudson Bay Capital Management »

Arcus Biosciences Incorporated shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2M 170k 19.10
2023-09-30 $1.4M 80k 17.95
2023-06-30 $2.3M 115k 20.31
2023-03-31 $2.1M 115k 18.24
2022-12-31 $1.0M 50k 20.68
2022-06-30 $786k 31k 25.35
2022-03-31 $316k 10k 31.60
2020-09-30 $1.5M 85k 17.14
2020-06-30 $2.7M 110k 24.74

More positions owned by Hudson Bay Capital Management

Amazon Call Option (AMZN)
Microsoft Corporation Put Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Meta Platforms Cl A Put Option (META)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
NVIDIA Corporation Put Option (NVDA)
salesforce Put Option (CRM)
Select Sector Spdr Tr Financial (XLF)
Adobe Systems Incorporated Put Option (ADBE)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Arcus Biosciences Incorporated

Vanguard Group
Octagon Capital Advisors
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Decheng Capital
Point72 Asset Management
Goldman Sachs Group
Bnp Paribas Investment Partners
Balyasny Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Ikarian Capital
Ubs Global Asset Management Americas

View all funds holding Arcus Biosciences Incorporated